First-Line Treatment for Tinea Infections

Treatment Selection Based on Site of Infection

For tinea capitis, the British Journal of Dermatology recommends oral griseofulvin 15-20 mg/kg/day for 6-8 weeks as the first-line treatment, although terbinafine offers a shorter treatment duration of 2-4 weeks 1, 2
For tinea corporis and tinea cruris, topical antifungal therapy is the first-line treatment for localized disease, while oral therapy is reserved for extensive infections, treatment failures, or immunocompromised patients, according to Praxis Medical Insights 3

Oral therapy is mandatory for tinea capitis, and topical therapy alone is not effective, as stated by the British Journal of Dermatology 1, 2
The British Journal of Dermatology recommends griseofulvin dosing of 15-20 mg/kg/day for patients less than 50 kg, or 1 g/day for patients over 50 kg, continued for 6-8 weeks 1
The British Journal of Dermatology suggests terbinafine alternative dosing of less than 20 kg: 62.5 mg/day; 20-40 kg: 125 mg/day; over 40 kg: 250 mg/day for 2-4 weeks 1
Organism-specific selection is critical, with terbinafine being more effective for Trichophyton species and griseofulvin being more effective for Microsporum species, according to the British Journal of Dermatology and Praxis Medical Insights 1, 2

The British Journal of Dermatology and Praxis Medical Insights recommend collecting specimens via scalpel scraping, hair pluck, brush, or swab as appropriate for diagnosis 1, 3

The British Journal of Dermatology suggests assessing compliance, drug absorption, organism sensitivity, and potential reinfection in cases of treatment failure 1
If clinical improvement occurs but mycology remains positive, the British Journal of Dermatology recommends continuing current therapy for an additional 2-4 weeks 1
If no clinical improvement, the British Journal of Dermatology suggests switching to second-line therapy, such as itraconazole or switching between terbinafine and griseofulvin based on organism 1

Griseofulvin has important contraindications, including lupus erythematosus, porphyria, and severe liver disease, as noted by the British Journal of Dermatology 1
Terbinafine is relatively ineffective against Microsporum species, according to the British Journal of Dermatology 1
The British Journal of Dermatology and Praxis Medical Insights recommend screening and treating family members for anthropophilic species like T. tonsurans, as over 50% of household contacts may be affected 1, 3
Praxis Medical Insights suggests cleaning all fomites with disinfectant or 2% sodium hypochlorite solution to prevent reinfection 3

Praxis Medical Insights states that mycological cure, not just clinical response, is the definitive treatment endpoint 2, 3
The British Journal of Dermatology recommends that children receiving appropriate therapy for tinea capitis should be allowed to attend school or nursery 1